CD19 and acute lymphoblastic leukemia: Tatar et al. suggested a new nanoparticle-based immunotherapeutic treatment against ALL involving an anti-CD19 antibody-conjugated, polyethylene glycol (PEG)-biocompatibilized, and Nile Blue (NB) Raman reporter-tagged gold nanoparticles of urchin-like shape (GNUs).